Melanoma/Skin Cancer News

The organizers of HemOnc Today New York canceled this year’s meeting amid growing concern about the spread of the new coronavirus.

The FDA granted fast track designation to tipifarnib for treatment of adults with one of several types of T-cell lymphoma, according to the agent’s manufacturer.

Self-reported lifetime prevalence of skin cancer was higher in gay and bisexual men compared with heterosexual men, according to a cross-sectional study published in JAMA Dermatology.

A large study of drinking habits in the oncology population revealed high rates of alcohol consumption among patients with and survivors of cancer.

Smartphone applications that use algorithms to assess the risk for skin cancer appear to have poor and variable performance, according to a systematic review of diagnostic accuracy studies.

In many respects, this year’s report of cancer incidence and mortality from American Cancer Society, Cancer Statistics 2020, tells a familiar story.

Patients with myocarditis related to immune checkpoint inhibitors and either a preserved or reduced ejection fraction had a reduced global longitudinal strain, according to a study published in the Journal of the American College of Cardiology.

Circulating tumor cells appeared independently associated with relapse among patients with stage III melanoma, according to results of a prospective study published in Clinical Cancer Research.

ASCO has named the refinement of surgical treatment of cancer as the Advance of the Year, recognizing emerging novel systemic therapies that changed the role of cancer surgery.

Adjuvant ipilimumab dosed at 3 mg/kg significantly improved OS compared with high-dose interferon alfa-2b among patients with metastatic unresectable melanoma, according to results of the phase 3 E1609 trial published in Journal of Clinical Oncology.